Clinical Trial: Study of Bortezomib and Panobinostat in Treating Patients With Relapsed/Refractory Peripheral T-cell Lymphoma or NK/T-cell Lymphoma

Sponsor and Collaborators
Singapore General Hospital

Contact
Contact: Daryl Tan, MBBS MRCP
65-63266604
daryl.tan@sgh.com.sg

Contact: Pei Woon ZN Eng, Bsc (hons)
65-63214627
eng.pei.woon@sgh.com.sg

Principal Investigator
Daryl Tan, MBBS MRCP Singapore General Hospital

ClinicalTrials.gov Identifier
NCT00901147